Differential Expression of Matrix Metalloproteinases and Inhibitors in Developing Rat Lung Mesenchymal and Epithelial Cells
0031-3998/07/6201-0020
PEDIATRIC RESEARCH
Copyright © 2007 International Pediatric Research Foundation, Inc.
Vol. 62, No. 1, 2007
Printed in U.S.A.
Differential Expression of Matrix Metalloproteinases
and Inhibitors in Developing Rat Lung Mesenchymal
and Epithelial Cells
OLIVIER BOUCHERAT, JACQUES R. BOURBON, ANNE-MARIE BARLIER-MUR, BERNADETTE CHAILLEY-HEU,
MARIE-PIA D’ORTHO, AND CHRISTOPHE DELACOURT
INSERM Unité 841, IMRB, Département Biologie et Thérapeutique Cardiorespiratoires et Hépatiques, Créteil, F-94000 France;
Université Paris 12, Faculté de Médecine, Créteil, F-94000 France
(6). The question of relative contributions is all the more
important in that reciprocal epithelial-mesenchymal interactions are crucial for all lung developmental steps (9). Moreover, more attention has been paid thus far to early fetal lung
development than to later stages. Further documenting late
development may help to better understand the significance of
changes in MMP activity associated with neonatal chronic
lung disease (10,11). In the present study, we investigated
expression changes in MMPs/TIMPs in fibroblasts and AECs
extemporaneously isolated from the rat lung, from the end of
pseudoglandular stage to alveolar stage. We also studied
comparatively cells expressing in vitro either the ATI or ATII
phenotype.
Because a global study of MMPs and TIMPs could not be
considered, we focused on proteins with known particular
importance, including MMP-2 and MT1-MMP (or MMP-14)
that are involved in alveolar formation (12–14), TIMP-1 (the
major MMP inhibitor), and TIMP-2, which controls MMP-2
activation (15). These are among the most expressed matrixremodeling molecules in the lung, as evidenced in a profiling study in various organs of the developing mouse (5).
Because we focused on late development, TIMP-3 that is
important earlier during branching morphogenesis (16) was
not included.
ABSTRACT: Lung development requires extracellular matrix remodeling. This involves matrix metalloproteinases (MMPs) and their
endogenous inhibitors [tissue inhibitors of metalloproteinases
(TIMPs)]. Because these have been generally studied only in whole
lung, we focused specifically on mesenchymal and epithelial cells
freshly isolated at various developmental stages. In fibroblasts, the
most striking developmental change was a peak (fourfold the prenatal
level) of membrane type 1 (MT1)-MMP transcript during alveolarization, consistent with the known crucial role of MT1-MMP in this
process. TIMP-1 and -2 mRNAs transiently increased on postnatal d
(pn) 3. In alveolar epithelial cells (AECs), MMP-2 expression was
maximal on fetal d (f) 19 when alveolar type II cells (ATII) differentiate and on pn5; by contrast, MT1-MMP expression changed little
and TIMP-1 expression decreased with advancing gestation. In cells
expressing in vitro the ATI phenotype, TIMP-1 and -2 activities were
nine- and fivefold those in cells expressing ATII features, respectively, whereas ATII presented higher MMP-2 activity and were the
only cell type to express MMP-9. This indicates higher remodeling
potential for ATII. Pulmonary mesenchymal and epithelial cells have
therefore quite distinct MMP/TIMP expression patterns. Changes in
cell compartments should be specifically documented in developing
lung diseases such as bronchopulmonary dysplasia in which changes
in MMP activities have been reported. (Pediatr Res 62: 20–25,
2007)
E
xtracellular matrix (ECM) is essential to lung morphogenesis and to cell differentiation, growth, and motility (1).
The successive pseudoglandular, canalicular, saccular, and
alveolar stages of lung development (2) all involve remodeling of ECM (1). Zinc-dependent endopeptidases, the MMPs,
carry out ECM proteolysis (3). Their activity is regulated
by various mechanisms in which TIMPs play a prominent
role (3).
A variety of MMPs and TIMPs are expressed in the developing lung (4,5). Although epithelial and mesenchymal cells
appear to have distinct MMP/TIMP expression features (4,6),
expression changes in MMPs and TIMPs across the different
developmental steps have generally been studied only in the
whole lung (4,5,7,8). When epithelial and mesenchymal cells
were studied comparatively, it was for a very limited period
MATERIALS AND METHODS
Lung cell isolation. Dated pregnant Sprague-Dawley rats (Charles River,
Saint Germain sur l’Arbresle, France) were used. Animal procedure was
authorized by the French Ministry of Agriculture. AECs and fibroblasts were
isolated by differential adhesion and centrifugation as described (17), on f17
(pseudoglandular stage), f19 (canalicular stage), f21, and pn1 and 3 (saccular
stage), pn5 and 8 (alveolar stage, progressing septation), and pn16 (alveolar
stage, terminated septation). Epithelial cells isolated by this procedure express
characteristic ATII markers (17). Freshly isolated cells were immediately
frozen without any culture step and stored at ⫺80°C.
AEC culture. To determine whether cells expressing the ATI or ATII
features have different MMP/TIMP equipment, AECs isolated on pn21 were
seeded on substrata reported to favor either phenotype. Engelbreth-Holm-
Abbreviations: AECs, alveolar epithelial cells; ATI (II), alveolar type I
(type II) cells; CF, collagen-fibronectin coating; CFL, collagen-fibronectinlaminin 5 coating; CM, conditioned medium; EHS matrix, EngelbrethHolm-Swarm basement-membrane matrix; f, fetal day; MMP, matrix metalloproteinase; pn, postnatal day; SP-B, surfactant protein B; TIMP, tissue
inhibitor of metalloproteinases
Received November 16, 2006; accepted February 16, 2007.
Correspondence: Jacques Bourbon, Ph.D., Inserm U841, Faculté de Médecine, 8 rue
du Général Sarrail, 94010 Créteil, France; e-mail:
This work was supported by regular INSERM funding without extramural source.
20
21
MMPs/TIMPs IN DEVELOPING RAT LUNG CELLS
Table 1. Sequences of primers used to amplify TIMP-1, TIMP-2, MMP-2, and MT1-MMP cDNA fragments
TIMP-1
TIMP-2
MMP-2
MT1-MMP
Forward (5=-3=)
Reverse (5=-3=)
cDNA length (bp)
TM
CCAGAAATCATCGAGACCACCT
ATTTATCTACACGGCCCC
TGATCTCCAGTGCCCTC
GTACTACCGCTTCAATGAGG
GGCAGGCAAAGTGATCGCTC
CAAGAACCATCACTTCTCTTG
TGGCGAACACAGCACTC
CACTGCCAGTACCAGGAG
420
341
410
363
55°C
58°C
60°C
58°C
Swarm basement membrane matrix [(EHS matrix) prepared in the laboratory]
and a coating designated collagen-fibronectin-laminin 5 coating (CFL) composed of collagen I (8 g/cm2; BD Biosciences, Erembodegem, Belgium),
fibronectin (2.1 g/cm2; Sigma Chemical Co., L’Isle d’Abeau-Chesnes,
France), and laminin 5 (0.5 g/cm2; gift from P. Rousselle, Institute of Protein
Biology and Chemistry, CNRS, Lyon, France), both support the ATII phenotype. Plastic and a collagen-fibronectin coating (CF), composed only of
collagen I and fibronectin (same concentrations), favor transdifferentiation
into ATI (18,19). Purified AECs in 10% fetal bovine serum (FBS)– containing
medium were seeded (1.5 ⫻ 106 cells/mL) in multiwell plastic culture plates
eith (...truncated)